Literature DB >> 22336291

Validation of a single-platform, volumetric, CD45-assisted PanLeucogating Auto40 flow cytometer to determine the absolute number and percentages of CD4 T cells in resource-constrained settings using Cameroonian patients' samples.

François-Xavier Mbopi-Kéou1, Stefano Mion, Bertrand Sagnia, Laurent Bélec.   

Abstract

The study evaluated the single-platform, volumetric, CD45-assisted PanLeucogating Auto40 flow cytometer (Apogee Flow Systems Ltd., Hemel Hempstead, United Kingdom) for CD4 T cell numeration, compared to the reference FACSCalibur flow cytometer. Results of absolute counts and percentages of CD4 T cells by Auto40 and FACSCalibur of 234 tripotassium EDTA (K3-EDTA)-blood samples from 146 adults and 88 children (aged from 18 months to 5 years), living in Yaoundé, Cameroon, were highly correlated (r(2) = 0.97 and r(2) = 0.98, respectively). The mean absolute bias and relative bias between Apogee Auto40 and FACSCalibur absolute CD4 T cell counts were +9.6 cells/μl, with limits of agreement from -251 to 270 cells/μl, and +4.1%, with limits of agreement from -16.1 to 24.4%, respectively. The mean absolute bias and relative bias between Apogee Auto40 and FACSCalibur CD4 T cell results expressed as percentages were +0.05% CD4 (95% confidence interval [CI], -0.03 to 0.41), with limits of agreement from -6.0 to 5.9% CD4, and +1.0%, with limits of agreement from -32.3 to 34.4%, respectively. The Auto40 counting allowed identification of the majority of adults with CD4 T cell counts below 200 cells/μl (sensitivity, 87%; specificity, 98%) or below 350 cells/μl (sensitivity, 92%; specificity, 98%) and of children with CD4 T cell counts below 750 cells/μl (sensitivity, 82%; specificity, 98%) or below 25% CD4(+) (sensitivity, 96%; specificity, 99%). The Auto40 analyzer is a reliable alternative flow cytometer for CD4 T lymphocyte enumeration to be used in routine immunological monitoring according to the WHO recommendations for HIV-infected adults as well as children living in resource-constrained settings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22336291      PMCID: PMC3318276          DOI: 10.1128/CVI.00023-12

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  30 in total

Review 1.  Challenges in implementing HIV laboratory monitoring in resource-constrained settings: how to do more with less.

Authors:  Laurent Bélec; Jean-Paul Bonn
Journal:  Future Microbiol       Date:  2011-11       Impact factor: 3.165

2.  Low cost CD4 enumeration using generic monoclonal antibody reagents and a two-color user-defined MultiSET protocol.

Authors:  Kovit Pattanapanyasat; Hla Shain; Varipin Prasertsilpa; Egarit Noulsri; Surada Lerdwana; Achara Eksaengsri
Journal:  Cytometry B Clin Cytom       Date:  2006-09-15       Impact factor: 3.058

3.  Performance of the Panleucogating protocol for CD4+ T cell enumeration in an HIV dedicated laboratory facility in Barbados.

Authors:  Namrata Sippy-Chatrani; Shauna Marshall; Songee Branch; Kelly Carmichael-Simmons; R Clive Landis; Akinola Abayomi
Journal:  Cytometry B Clin Cytom       Date:  2008       Impact factor: 3.058

4.  High impact of mobile units for mass HIV testing in Africa.

Authors:  François-Xavier Mbopi-Kéou; Pierre Ongolo-Zogo; Fru Angwafo; Peter Martins Ndumbe; Laurent Bélec
Journal:  AIDS       Date:  2007-09-12       Impact factor: 4.177

Review 5.  Evaluation of a flow cytometry method for CD4 T cell enumeration based on volumetric primary CD4 gating using thermoresistant reagents.

Authors:  Tandakha Ndiaye Dieye; Papa Alassane Diaw; Géraldine Daneau; Djibril Wade; Maguette Sylla Niang; Makhtar Camara; Abdoul Aziz Diallo; Coumba Toure Kane; Halimatou Diop Ndiaye; Babacar Mbengue; Alioune Dieye; Luc Kestens; Souleymane Mboup
Journal:  J Immunol Methods       Date:  2011-07-29       Impact factor: 2.303

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  Immunologic differentiation of absolute lymphocyte count with an integrated flow cytometric system: a new concept for absolute T cell subset determinations.

Authors:  T J Mercolino; M C Connelly; E J Meyer; M D Knight; J W Parker; G T Stelzer; G DeChirico
Journal:  Cytometry       Date:  1995-03-15

8.  A multicenter evaluation of the PanLeucogating method and the use of generic monoclonal antibody reagents for CD4 enumeration in HIV-infected patients in Thailand.

Authors:  Kovit Pattanapanyasat; Hla Shain; Egarit Noulsri; Surada Lerdwana; Charin Thepthai; Varipin Prasertsilpa; Sirirat Likanonsakul; Prakit Yothipitak; Somboon Nookhai; Achara Eksaengsri
Journal:  Cytometry B Clin Cytom       Date:  2005-05       Impact factor: 3.058

Review 9.  Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis.

Authors:  B Brando; D Barnett; G Janossy; F Mandy; B Autran; G Rothe; B Scarpati; G D'Avanzo; J L D'Hautcourt; R Lenkei; G Schmitz; A Kunkl; R Chianese; S Papa; J W Gratama
Journal:  Cytometry       Date:  2000-12-15

Review 10.  CD4 T cell measurements in the management of antiretroviral therapy--A review with an emphasis on pediatric HIV-infected patients.

Authors:  Maurice R G O'Gorman; Lynn S Zijenah
Journal:  Cytometry B Clin Cytom       Date:  2008       Impact factor: 3.058

View more
  7 in total

1.  Laboratory and field evaluation of the Partec CyFlow miniPOC for absolute and relative CD4 T-cell enumeration.

Authors:  Djibril Wade; Papa Alassane Diaw; Géraldine Daneau; Abdoul Aziz Diallo; Souleymane Mboup; Tandakha Ndiaye Dieye; Luc Kestens
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

2.  WHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patients.

Authors:  Djibril Wade; Géraldine Daneau; Said Aboud; Gaby H Vercauteren; Willy S K Urassa; Luc Kestens
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-15       Impact factor: 3.731

Review 3.  CD4 enumeration technologies: a systematic review of test performance for determining eligibility for antiretroviral therapy.

Authors:  Rosanna W Peeling; Kimberly A Sollis; Sarah Glover; Suzanne M Crowe; Alan L Landay; Ben Cheng; David Barnett; Thomas N Denny; Thomas J Spira; Wendy S Stevens; Siobhan Crowley; Shaffiq Essajee; Marco Vitoria; Nathan Ford
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

4.  Performance evaluation of the touchscreen-based Muse™ Auto CD4/CD4% single-platform system for CD4 T cell numeration in absolute number and in percentage using blood samples from children and adult patients living in the Central African Republic.

Authors:  Christian Diamant Mossoro-Kpinde; André Kouabosso; Ralph-Sydney Mboumba Bouassa; Jean De Dieu Longo; Edouard Kokanzo; Rosine Féissona; Gérard Grésenguet; Laurent Bélec
Journal:  J Transl Med       Date:  2016-11-25       Impact factor: 5.531

5.  Single-platform, volumetric, CD45-assisted pan-leucogating flow cytometry for CD4 T lymphocytes monitoring of HIV infection according to the WHO recommendations for resource-constrained settings.

Authors:  Donato Koyalta; Mohammad-Ali Jenabian; Ngamasra Nadjiouroum; Barou Djouater; Noël Djemadji-Oudjeil; Angélique Ndjoyi-Mbiguino; Laurent Bélec
Journal:  BMC Res Notes       Date:  2013-04-30

6.  Field evaluation in Chad of community usage of CD4 T lymphocyte counting by alternative single-platform flow cytometry.

Authors:  Donato Koyalta; Mohammad-Ali Jenabian; Barou Djouater; Noël Djemadji-Oudjeil; Francois-Xavier Mbopi-Keou; Angélique Ndjoyi-Mbiguino; Laurent Bélec
Journal:  BMC Health Serv Res       Date:  2013-10-01       Impact factor: 2.655

7.  Performance Evaluation of the Becton Dickinson FACSPresto™ Near-Patient CD4 Instrument in a Laboratory and Typical Field Clinic Setting in South Africa.

Authors:  Lindi-Marie Coetzee; Keshendree Moodley; Deborah Kim Glencross
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.